Zheng Jiao

2.5k total citations
109 papers, 1.9k citations indexed

About

Zheng Jiao is a scholar working on Pediatrics, Perinatology and Child Health, Transplantation and Psychiatry and Mental health. According to data from OpenAlex, Zheng Jiao has authored 109 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pediatrics, Perinatology and Child Health, 31 papers in Transplantation and 29 papers in Psychiatry and Mental health. Recurrent topics in Zheng Jiao's work include Pharmacological Effects and Toxicity Studies (32 papers), Renal Transplantation Outcomes and Treatments (31 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Zheng Jiao is often cited by papers focused on Pharmacological Effects and Toxicity Studies (32 papers), Renal Transplantation Outcomes and Treatments (31 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Zheng Jiao collaborates with scholars based in China, South Korea and United States. Zheng Jiao's co-authors include Mingkang Zhong, Xiaojin Shi, Xiaoyan Qiu, Chun-Lai Ma, Junjie Ding, Junjun Mao, Chenyu Wang, Chenyan Zhao, Yunqiu Yu and Zhongdong Li and has published in prestigious journals such as Journal of the American Chemical Society, Nano Letters and PLoS ONE.

In The Last Decade

Zheng Jiao

98 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zheng Jiao China 27 663 532 491 366 293 109 1.9k
Raymond G. Morris Australia 24 666 1.0× 351 0.7× 729 1.5× 325 0.9× 184 0.6× 92 1.8k
Ikuko Yano Japan 26 819 1.2× 212 0.4× 539 1.1× 378 1.0× 184 0.6× 170 2.4k
Nicolas Picard France 29 697 1.1× 200 0.4× 968 2.0× 196 0.5× 340 1.2× 81 2.5k
Franck Saint‐Marcoux France 29 417 0.6× 187 0.4× 802 1.6× 248 0.7× 182 0.6× 101 2.0k
Tony K. L. Kiang Canada 21 375 0.6× 254 0.5× 185 0.4× 246 0.7× 212 0.7× 54 1.5k
Annick Rousseau France 30 694 1.0× 393 0.7× 1.6k 3.3× 246 0.7× 363 1.2× 74 2.5k
Leo Stolk Netherlands 23 544 0.8× 152 0.3× 434 0.9× 623 1.7× 216 0.7× 68 2.4k
Mingkang Zhong China 25 291 0.4× 221 0.4× 231 0.5× 241 0.7× 120 0.4× 100 1.7k
Walid M. Awni United States 30 602 0.9× 138 0.3× 404 0.8× 454 1.2× 416 1.4× 139 3.0k
Richard C. Brundage United States 38 1.1k 1.7× 546 1.0× 336 0.7× 389 1.1× 1.5k 5.0× 136 3.8k

Countries citing papers authored by Zheng Jiao

Since Specialization
Citations

This map shows the geographic impact of Zheng Jiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Jiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Jiao more than expected).

Fields of papers citing papers by Zheng Jiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng Jiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Jiao. The network helps show where Zheng Jiao may publish in the future.

Co-authorship network of co-authors of Zheng Jiao

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Jiao. A scholar is included among the top collaborators of Zheng Jiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Jiao. Zheng Jiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Methaneethorn, Janthima, et al.. (2025). Pharmacokinetic interactions of fruit juices with antihypertensive drugs in humans: A systematic review and meta-analysis. Complementary Therapies in Medicine. 90. 103165–103165. 1 indexed citations
2.
Wan, Haixiao, Zheng Jiao, Jiaqi Li, et al.. (2025). Dynamic Interplay between Deformability and Activity in Cell Entry of Soft Active Nanoparticles. Nano Letters. 25(16). 6797–6802. 1 indexed citations
4.
Liu, Yun, Hong‐Li Guo, Keyu Lu, et al.. (2024). A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models. European Journal of Pharmaceutics and Biopharmaceutics. 204. 114484–114484.
5.
Zhang, Xuanyu, Xiaobin Dai, Haixiao Wan, et al.. (2024). Interfaces Between Nanoparticle and Biomacromolecular Network: Dynamic Behaviors, Confinement and Entropy. Advanced Functional Materials. 34(32).
6.
Zeng, Liyan, Feng Li, Zhaoqin Zhu, et al.. (2024). Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID‐19. Fundamental and Clinical Pharmacology. 38(4). 767–779. 1 indexed citations
8.
Jiao, Zheng, Lijuan Gao, Jiaqi Li, et al.. (2024). Nonequilibrium Dynamics at Cellular Interfaces: Insights From Simulation and Theory. Wiley Interdisciplinary Reviews Computational Molecular Science. 14(6). 1 indexed citations
9.
Yang, Yang, Chenyu Wang, Yueting Chen, et al.. (2024). Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis. Acta Pharmacologica Sinica. 45(10). 2212–2225.
10.
Jiao, Zheng, Yun Shen, Zhe Chen, et al.. (2023). External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients. Journal of Global Antimicrobial Resistance. 35. 347–353. 1 indexed citations
11.
Chen, Yueting, Yang Yang, Chenyu Wang, et al.. (2023). Model Informed Development of SIM0295 in Patients with Gout and Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/ Pharmacodynamics Approach. Expert Opinion on Investigational Drugs. 32(5). 441–450. 1 indexed citations
12.
Liu, Xiaoqin, Ziran Li, Chenyu Wang, Yueting Chen, & Zheng Jiao. (2023). Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban. Pharmaceutics. 15(2). 588–588. 11 indexed citations
13.
Cai, Xinjun, et al.. (2023). Parametric population pharmacokinetics of isoniazid: a systematic review. Expert Review of Clinical Pharmacology. 16(5). 467–489. 6 indexed citations
14.
Li, Ziran, et al.. (2022). Handling Delayed or Missed Dose of Antiseizure Medications. Neurology. 100(9). e921–e931. 9 indexed citations
15.
Zhang, Lili, et al.. (2022). Parametric population pharmacokinetics of linezolid: A systematic review. British Journal of Clinical Pharmacology. 88(9). 4043–4066. 15 indexed citations
16.
Chen, Yueting, et al.. (2021). Population pharmacokinetics of oxcarbazepine: a systematic review. Expert Review of Clinical Pharmacology. 14(7). 853–864. 17 indexed citations
17.
Cai, Weimin, et al.. (2020). Investigating the interaction between nifedipine‐ and ritonavir‐containing antiviral regimens: A physiologically based pharmacokinetic/pharmacodynamic analysis. British Journal of Clinical Pharmacology. 87(7). 2790–2806. 11 indexed citations
18.
Ma, Chun-Lai, Xunyi Wu, Zheng Jiao, et al.. (2015). SCN1A, ABCC2 and UGT2B7 Gene Polymorphisms in Association with Individualized Oxcarbazepine Therapy. Pharmacogenomics. 16(4). 347–360. 39 indexed citations
20.
Jiao, Zheng, et al.. (2006). Study on Bioequivalence of Risperidone Tablets. Zhōnghuá yàoxué zázhì. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026